Ariadna Torrella

815 total citations
18 papers, 346 citations indexed

About

Ariadna Torrella is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Ariadna Torrella has authored 18 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 8 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Ariadna Torrella's work include HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (4 papers). Ariadna Torrella is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (4 papers). Ariadna Torrella collaborates with scholars based in Spain, Belgium and Cuba. Ariadna Torrella's co-authors include Jordi Navarro, Esteban Ribera, Adrián Curran, Vicenç Falcó, Joaquín Burgos, Bibiana Planas, María J. Buzón, Judith Grau-Expósito, Meritxell Genescà and I Ocaña and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and International Journal of Epidemiology.

In The Last Decade

Ariadna Torrella

18 papers receiving 337 citations

Peers

Countries citing papers authored by Ariadna Torrella

Since Specialization

Citations

This map shows the geographic impact of Ariadna Torrella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariadna Torrella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariadna Torrella more than expected).

Fields of papers citing papers by Ariadna Torrella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariadna Torrella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariadna Torrella. The network helps show where Ariadna Torrella may publish in the future.

Co-authorship network of co-authors of Ariadna Torrella

This figure shows the co-authorship network connecting the top 25 collaborators of Ariadna Torrella. A scholar is included among the top collaborators of Ariadna Torrella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariadna Torrella. Ariadna Torrella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Schistosomiasis Among Female Migrants in Non-endemic Countries: Neglected Among the Neglected? A Pilot Study 2022 ·Frontiers in Public Health ·Sílvia Roure, (unknown), Xavier Vallès, Lluís Valerio, (unknown), Laura Soldevila, Ariadna Torrella, Gema Fernández‐Rivas, Anna Chamorro, Bonaventura Clotet	10
2	COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial 2022 ·Journal of Personalized Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Manuel Requena, Ariadna Torrella, Bibiana Planas, Berta Raventós, Carlos A. Molina, Marc Ribó, Benito Almirante, Óscar Len	4
3	SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain 2022 ·Emerging infectious diseases ·(unknown), Ariadna Torrella, (unknown), (unknown), Elisa Martró, Antoni E. Bordoy, Verónica Saludes, Ignacio Blanco, Laura Soldevila, Oriol Estrada, Lluís Valerio, Sílvia Roure, Xavier Vallès	10
4	Identification of HIV-Reservoir Cells With Reduced Susceptibility to Antibody-Dependent Immune Response 2021 ·SSRN Electronic Journal ·Antonio Astorga-Gamaza, Judith Grau-Expósito, Joaquín Burgos, Jordi Navarro, Adrián Curran, Berta Raventós, Ariadna Torrella, Bibiana Planas, Paula Suanzes, Vicenç Falcó, Meritxell Genescà, María J. Buzón	1
5	Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study 2021 ·HIV Medicine ·Adaia Albasanz‐Puig, Paula Suanzes, Juliana Esperalba, Candela Fernández‐Naval, Júlia Sellarès-Nadal, Ariadna Torrella, Bibiana Planas, (unknown), Joaquín Burgos, Esteban Ribera, Esperanza Cañas‐Ruano, Jorge García, Jordi Navarro, Adrián Curran, Óscar Len, Vicenç Falcó	7
6	Exploration of clients living with HIV needs for reporting on experiences with sex 2020 ·Nursing and Health Sciences ·Juan M. Leyva‐Moral, María Feijoo-Cid, Ariadna Torrella, (unknown), (unknown), (unknown), Jordi Navarro, Mariela Aguayo–González	6
7	Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial 2020 ·Journal of Clinical Medicine ·Adrián Curran, Anna Rull, Jordi Navarro, Judit Vidal‐González, (unknown), Joaquín Burgos, Vicenç Falcó, Esteban Ribera, Ariadna Torrella, Bibiana Planas, Joaquim Peraire, Manuel Crespo	11
8	Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab 2019 ·Nature Communications ·Carla Serra‐Peinado, Judith Grau-Expósito, (unknown), Antonio Astorga-Gamaza, Jordi Navarro, (unknown), (unknown), Adrián Curran, Joaquín Burgos, Esteban Ribera, Berta Raventós, (unknown), Ariadna Torrella, Bibiana Planas, (unknown), Felipe García, Josep Castellví, Meritxell Genescà, Vicenç Falcó, María J. Buzón	34
9	Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations 2019 ·PLoS Pathogens ·Judith Grau-Expósito, (unknown), Jordi Navarro, Adrián Curran, Joaquín Burgos, Esteban Ribera, Ariadna Torrella, Bibiana Planas, (unknown), (unknown), Jesús Fernández‐Sojo, Meritxell Genescà, Vicenç Falcó, María J. Buzón	107
10	Switching From a Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy–suppressed Human Immunodeficiency Virus–infected Individuals 2018 ·Clinical Infectious Diseases ·Sara Morón‐López, Jordi Navarro, (unknown), Sofie Rutsaert, Víctor Urrea, María C. Puertas, Ariadna Torrella, (unknown), (unknown), Cristina Gálvez, María Salgado, Linos Vandekerckhove, Julià Blanco, Manel Crespo, Javier Martínez‐Picado	13
11	A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 ⁺ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients 2017 ·mBio ·Judith Grau-Expósito, Carla Serra‐Peinado, (unknown), Jordi Navarro, Adrián Curran, Joaquín Burgos, I Ocaña, Esteban Ribera, Ariadna Torrella, Bibiana Planas, (unknown), Josep Castellví, Vicenç Falcó, Manuel Crespo, María J. Buzón	81
12	Acute Leg Ischaemia in an HIV-Infected Patient Receiving Antiretroviral Treatment 2016 ·Antiviral Therapy ·Jordi Navarro, Adrián Curran, Joaquín Burgos, Ariadna Torrella, I Ocaña, Vicenç Falcó, Manuel Crespo, Esteban Ribera	7
13	Impact of Low-Level Viraemia on Virological Failure in HIV-1-Infected Patients with Stable Antiretroviral Treatment 2015 ·Antiviral Therapy ·Jordi Navarro, Estrella Caballero, Adrián Curran, Joaquín Burgos, I Ocaña, Vicenç Falcó, Ariadna Torrella, Mercè Pérez‐Riba, Esteban Ribera, Manuel Crespo	12
14	Impact of an Adherence Program to Antiretroviral Treatment on Virologic Response in a Cohort of Multitreated and Poorly Adherent HIV-Infected Patients in Spain 2014 ·AIDS Patient Care and STDs ·Jordi Navarro, Mercè Pérez‐Riba, Adrián Curran, Joaquín Burgos, María Feijoo-Cid, Ariadna Torrella, Estrella Caballero, I Ocaña, Esteban Ribera, Manel Crespo, Vicenç Falcó	6
15	Vacunas en melanoma 2004 ·(unknown), Ariadna Torrella	1
16	265 First clinical evidences of antigen spreading in metastatic melanoma patients treated with a NGcGM3/VSSP/Montanide ISA 51 vaccine: a phase I/IIb study 2004 ·European Journal of Cancer Supplements ·Giselle Saurez, (unknown), (unknown), Adriana Carr, (unknown), (unknown), Ariadna Torrella, J. González, (unknown), (unknown)	1
17	Human immunodeficiency virus (HIV) infection in parenteral drug users: evolution of the epidemic over 10 years. Valencian Epidemiology and Prevention of HIV Disease Study Group 1999 ·International Journal of Epidemiology ·Ildefonso Hernández‐Aguado, (unknown), Santiago Pérez‐Hoyos, (unknown), Iñaki Ruiz‐Pérez, Ariadna Torrella, Manuela García de la Hera, F. J. Belda, Esteve Fernández, (unknown), (unknown), (unknown)	22
18	Sharing of Injection Equipment among 3755 Intravenous Drug Users in Valencia, Spain, 1987–1992 1994 ·International Journal of Epidemiology ·Ildefonso Hernández‐Aguado, Isabel Ruíz-Camps, Francisco Bolúmar, Santiago Pérez‐Hoyos, Elena Fernández‐García, (unknown), Ariadna Torrella, Manuela García de la Hera, (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact